These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1052 related items for PubMed ID: 17139379

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ, Santos GR, Mourão PA.
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides.
    Fonseca RJ, Oliveira SN, Pomin VH, Mecawi AS, Araujo IG, Mourão PA.
    Thromb Haemost; 2010 May; 103(5):994-1004. PubMed ID: 20352164
    [Abstract] [Full Text] [Related]

  • 6. Different antithrombotic mechanisms among glycosaminoglycans revealed with a new fucosylated chondroitin sulfate from an echinoderm.
    Pacheco RG, Vicente CP, Zancan P, Mourão PA.
    Blood Coagul Fibrinolysis; 2000 Sep; 11(6):563-73. PubMed ID: 10997797
    [Abstract] [Full Text] [Related]

  • 7. Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans.
    Zancan P, Mourão PA.
    Blood Coagul Fibrinolysis; 2004 Jan; 15(1):45-54. PubMed ID: 15166943
    [Abstract] [Full Text] [Related]

  • 8. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
    Fonseca RJ, Oliveira SN, Melo FR, Pereira MG, Benevides NM, Mourão PA.
    Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
    [Abstract] [Full Text] [Related]

  • 9. Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers.
    Liu X, Hao J, Shan X, Zhang X, Zhao X, Li Q, Wang X, Cai C, Li G, Yu G.
    Carbohydr Polym; 2016 Nov 05; 152():343-350. PubMed ID: 27516281
    [Abstract] [Full Text] [Related]

  • 10. Improved anticoagulant effect of fucosylated chondroitin sulfate orally administered as gastro-resistant tablets.
    Fonseca RJ, Sucupira ID, Oliveira SN, Santos GR, Mourão PA.
    Thromb Haemost; 2017 Apr 03; 117(4):662-670. PubMed ID: 28102426
    [Abstract] [Full Text] [Related]

  • 11. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar 03; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of AR-H067637, the active metabolite of the new direct thrombin inhibitor AZD0837, in models of venous and arterial thrombosis and bleeding in anaesthetised rats.
    Pehrsson S, Johansson K, Kjaer M, Elg M.
    Thromb Haemost; 2010 Dec 03; 104(6):1242-9. PubMed ID: 20806126
    [Abstract] [Full Text] [Related]

  • 13. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR, Nazareth RA, Mourão PA.
    Thromb Haemost; 2001 Dec 03; 86(6):1540-6. PubMed ID: 11776325
    [Abstract] [Full Text] [Related]

  • 14. Sulfation pattern of the fucose branch is important for the anticoagulant and antithrombotic activities of fucosylated chondroitin sulfates.
    Chen S, Li G, Wu N, Guo X, Liao N, Ye X, Liu D, Xue C, Chai W.
    Biochim Biophys Acta; 2013 Apr 03; 1830(4):3054-66. PubMed ID: 23313164
    [Abstract] [Full Text] [Related]

  • 15. Anticoagulant and antithrombotic activities of a chemically sulfated galactoglucomannan obtained from the lichen Cladonia ibitipocae.
    Martinichen-Herrero JC, Carbonero ER, Sassaki GL, Gorin PA, Iacomini M.
    Int J Biol Macromol; 2005 Mar 03; 35(1-2):97-102. PubMed ID: 15769521
    [Abstract] [Full Text] [Related]

  • 16. Antithrombotic efficacy of thrombin inhibitor L-374,087: intravenous activity in a primate model of venous thrombus extension and oral activity in a canine model of primary venous and coronary artery thrombosis.
    Cook JJ, Gardell SJ, Holahan MA, Sitko GR, Stump GL, Wallace AA, Gilberto DB, Hare TR, Krueger JA, Dyer DL, Sanderson PE, Vacca JP, Shafer JA, Lynch JJ.
    J Pharmacol Exp Ther; 1999 Apr 03; 289(1):503-10. PubMed ID: 10087043
    [Abstract] [Full Text] [Related]

  • 17. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
    Gray A, Litinas E, Jeske W, Fareed J, Hoppensteadt D.
    Clin Appl Thromb Hemost; 2012 Apr 03; 18(2):166-73. PubMed ID: 22311630
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of thrombin by a fucosylated chondroitin sulfate from echinoderm.
    Mourão PA, Boisson-Vidal C, Tapon-Bretaudière J, Drouet B, Bros A, Fischer A.
    Thromb Res; 2001 Apr 15; 102(2):167-76. PubMed ID: 11323028
    [Abstract] [Full Text] [Related]

  • 19. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C, Yu A, Yuan B, Dong C, Yu H, Wang L, Wu C.
    Thromb Haemost; 2008 Feb 15; 99(2):324-30. PubMed ID: 18278181
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological actions of sulodexide.
    Ofosu FA.
    Semin Thromb Hemost; 1998 Feb 15; 24(2):127-38. PubMed ID: 9579633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.